SF3B1 mutations in chronic lymphocytic leukemia. - sprookjes - yvandenbroek - TriplyDB

SF3B1 mutations in chronic lymphocytic leukemia.

SF3B1 mutations in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q27852162

about

CIViC database Cancer-relevant Splicing Factor CAPERα Engages the Essential Splicing Factor SF3b155 in a Specific Ternary Complex The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing The splicing modulator sudemycin induces a specific antitumor response and cooperates with ibrutinib in chronic lymphocytic leukemia.Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.Genomic data integration in chronic lymphocytic leukemia.SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast Tumorigenesis promotes Mdm4-S overexpression.Systematic genomic and translational efficiency studies of uveal melanoma.Transcriptional diversity during lineage commitment of human blood progenitors.Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancers Herboxidiene triggers splicing repression and abiotic stress responses in plants.Using the geometric mean fluorescence intensity index method to measure ZAP-70 expression in patients with chronic lymphocytic leukemia.Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion.A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis Molecular pathogenesis of myelodysplastic syndromes.Splicing factor mutations and cancer.Evolving understanding of the CLL genome.How mRNA is misspliced in acute myelogenous leukemia (AML)?Alternative splicing of DNA damage response genes and gastrointestinal cancers.New drug discovery approaches targeting recurrent mutations in chronic lymphocytic leukemia.New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.Mechanisms of Resistance to Targeted Therapies in Chronic Lymphocytic Leukemia.Identification of potential therapeutic target genes and miRNAs for primary myelofibrosis with microarray analysis.A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity.SF3B1 mutation is a prognostic factor in chronic lymphocytic leukemia: a meta-analysis.Significance of duon mutations in cancer genomes.Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells.Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide.Proteomics profiling of CLL versus healthy B-cells identifies putative therapeutic targets and a subtype-independent signature of spliceosome dysregulation.MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.How I treat patients with relapsed chronic lymphocytic leukaemia.Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia

P2860

e7e61c57f9f30d8e43b8e314882e2daa00f6e0f4

P248

Q27612411-26AEF1BD-736C-4FCA-B5B0-6F5E6C066FBF Q27683637-B1665CF9-F167-4178-AE94-8ED9B87AA335 Q28083838-E9AB9A72-D695-4374-A3D5-7B2022E6658A Q28087672-CBB0FF50-8190-4DAE-A761-D577518963E1 Q28547976-88833F56-C8F5-49F8-857B-D6AA82B42BEF Q30395427-DE9FBB22-BDB9-4E56-8611-07834C16DB01 Q30685440-6954DEC5-DB44-42C1-A211-367AD513E270 Q31147488-A51FB524-E590-42D6-ABBD-3E862C00604F Q33635951-033075C6-ECE4-4643-B745-06632D64E94D Q33688440-DC349C87-11E8-479F-881A-09E2FA94899B Q33778295-E40B0F61-CED8-41A4-B791-1098FBF1895E Q34626417-C2654341-4346-4173-A4B8-68424BAEEC91 Q35577014-A8FE4B6C-BB2A-4381-8A2B-ECB126990449 Q36324293-CD7E219E-958A-4F96-A335-1D956438D6F7 Q36603887-5A20AFD7-0102-4954-8778-61E2AFF32D68 Q36998431-70C53FE1-7CE5-4DBE-8578-BFBB0B0F4FA1 Q37587994-6065053F-86A2-4F91-9906-234F4205C1C3 Q37662278-1D5765EA-4C69-4585-9048-1361BFCD1EB0 Q37680426-E230EC0E-D6E2-4AF7-BD4B-9CA6DB0B44A8 Q37724602-2056F187-3327-4A9E-92C1-E24AE5D3CF38 Q38187632-2EEB4BBD-45CD-4841-8AAC-E8E8B51C6752 Q38232481-117FD9D4-2474-412C-9397-B507DD82A641 Q38265600-595217E4-A6BE-4D3D-BA3C-012D9A6D8662 Q38291477-1EDAE319-7114-4D01-B3E3-2E3257A68294 Q38646974-A3B9C6A3-A796-4CDC-BF24-3DBC481A8A18 Q38714354-D155B076-4DBA-4F52-9F6B-4AEF4964CCB7 Q39169789-611D528F-307E-4B87-8DEC-9512D70424ED Q41665045-2FE0A2AA-C906-45CE-9E6A-19FCE75DBC8E Q42176799-DFC48F8B-D313-407E-8E15-1D458CD7816C Q42290445-9103D18E-5C20-4319-8C9A-51B3FF460E2E Q42378392-1DEC7181-3ADD-44D1-AF66-2926E8285F49 Q42737899-DBEE2C02-DD6E-4FBB-83E1-C324DB2FBD6A Q43113067-EAA735F1-3DF8-49FE-938F-332EF14859C2 Q48191937-FA6F76C3-C19A-4669-9E11-A0E9A5B274FB Q49788400-0F0AC062-DDE3-4A04-850F-91241893757A Q49788568-97854F35-8C6D-4156-8BBE-9D2C257F071C Q50277334-5F687B96-871D-4B97-BD87-B138904E92BF Q54348577-8836FC56-115E-4CDD-BE5E-779406DC1CF8 Q57170496-046EB4A2-F963-46EF-B5AE-7558DD906771

P2860

SF3B1 mutations in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q27852162

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

SF3B1 mutations in chronic lymphocytic leukemia.

@ast

SF3B1 mutations in chronic lymphocytic leukemia.

@en

SF3B1 mutations in chronic lymphocytic leukemia.

@nl

type

label

SF3B1 mutations in chronic lymphocytic leukemia.

@ast

SF3B1 mutations in chronic lymphocytic leukemia.

@en

SF3B1 mutations in chronic lymphocytic leukemia.

@nl

altLabel

SF3B1 mutations in chronic lymphocytic leukemia

@en

prefLabel

SF3B1 mutations in chronic lymphocytic leukemia.

@ast

SF3B1 mutations in chronic lymphocytic leukemia.

@en

SF3B1 mutations in chronic lymphocytic leukemia.

@nl

P1433

Q27852162-F3489B1E-3EC4-4D4E-B915-C20D77ABE045

P1476

Q27852162-25B02FE4-861E-435C-A706-E1A67BD6DF7B

P2093

Q27852162-3AE7B7FE-CA72-4068-A4A9-327D707B634F

Q27852162-5490E49E-1085-443A-825E-92C0318737A8

P2860

Q27852162-04BAA840-2E6B-4C42-A46F-789187DAAD82

Q27852162-059B72A4-4C58-4557-BE41-812CB813B2DE

Q27852162-06589188-0CBC-45BE-BCA6-F073085A5B1E

Q27852162-101A396B-33D2-448E-8F49-0463EDDC8645

Q27852162-191F6C4E-0B87-4C52-B4FF-AEE2F8A31F89

Q27852162-1B2F6A97-BE73-4DD5-AD04-5D10418BBB9C

Q27852162-39C9CB86-267F-484D-B73E-CAC5CC4B8407

Q27852162-3DC4443F-CB77-4AD0-94DA-75B6B7B77CA9

Q27852162-4B40DF43-A10D-4415-A399-1045DE3A818F

Q27852162-532DA276-6414-4530-AA59-6BD204CD1FC7

P304

Q27852162-FFEAAC1E-02FF-41E6-B013-3616D5CE6EF0

P31

Q27852162-FE973D15-1452-4DAC-9CBB-554457D0B259

P3181

Q27852162-097F429A-D9A2-4BD1-9B7D-278A10948D8B

P356

Q27852162-A7E422E8-16D2-4D76-A99E-D068E14CCE99

P407

Q27852162-638A4522-A407-41C9-B596-2D8F987EEF0B

P433

Q27852162-38B121C2-6F0F-493B-8CAE-B4741C1C4E70

P478

Q27852162-7C68C4DE-FDE7-4DCE-8327-B0D89974247B

P577

Q27852162-8853F59E-B486-404F-A1F8-6A993032453C

P5875

Q27852162-653DEAA2-EFE1-43E3-809E-277DC6227481

P698

Q27852162-FAB03E80-3C5F-4434-BC02-E0FCA88B0025

P921

Q27852162-26308AB5-B8E9-48A4-A0DC-69460356643C

Q27852162-2C9C2CA8-E8D5-4B30-AB9C-E60B316D3FAD

Q27852162-F95A4643-D99C-4654-91B0-588B1700ABBE

P932

Q27852162-EB11C179-756B-4D45-B379-6A13F8CC93AD

P3181

P356

BLOOD-2013-02-427641

P1433

P1476

SF3B1 mutations in chronic lymphocytic leukemia.

@en

P2093

Catherine J Wu

http://www.w3.org/2001/XMLSchema#string

Youzhong Wan

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis

A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms

Comprehensive molecular portraits of human breast tumours

A census of human cancer genes

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

The spliceosome: design principles of a dynamic RNP machine

Genomic aberrations and survival in chronic lymphocytic leukemia

P304

4627-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

936814

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2013-02-427641

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236139941

http://www.w3.org/2001/XMLSchema#string

P698

23568491

http://www.w3.org/2001/XMLSchema#string

P921

P932

3674664

http://www.w3.org/2001/XMLSchema#string